2023年6月5日,Avadel制药宣布LUMRYZ现已上市。LUMRYZ是一种羟丁酸钠缓释口服混悬剂,睡前服用一次,用于治疗发作性睡病成人患者的猝倒或白天过度嗜睡(EDS)。原文:
网页链接查看全文
产业链观察2023-03-30 16:25
#药闻简讯# 2023 年 3 月 29 日,专注于通过药物改造来改变生活的生物制药公司$Avadel制药(AVDL)$ 今天宣布与 RTW Investments, LP 及其某些附属公司签订特许权使用费协议高达 7500 万美元,以支持 LUMRYZ ™的潜在商业化,用于治疗发作性睡病成人的猝倒症或白天过度嗜睡( EDS )。 同时,该公...查看全文
美股滚雪球2023-02-27 09:37
$Avadel制药(AVDL)$ 寻求FDA对其睡眠障碍疗法Lumryz的最终批准,因为$爵士制药(JAZZ)$ 因专利纠纷败诉。
FDA已经初步批准Lumryz治疗成人嗜睡症患者的过度白天嗜睡(EDS)或猝倒。
然而,Jazz(Jazz)根据美国专利第8731963号(REMS专利)对Lumryz的知识产权提出了异议,该专利在FDA的橙皮...查看全文
牛唐2022-05-31 22:05
医药板块速评(2022.05.30)
本期内容提示:
1、市值低于现金,机构多次加仓的烟蒂股是否会迎来反弹机会?
2、嗜睡症药物公司$Avadel制药(AVDL)$ 期权活跃,后续走势如何看?
3、$天境生物(IMAB)$ 暴跌,是否有抄底机会?
$百济神州-U(SH688235)$查看全文
chuminhua2022-05-27 14:29
5月26日,Avadel Pharmaceuticals 股价周四下跌多达 63%,此前该公司披露专利问题可能会将 FDA 对其在研嗜睡症治疗药物 FT218 的批准推迟到 2023 年 6 月。该药为每晚一次的羟丁酸钠制剂,用于嗜睡症成人患者白天过度嗜睡和猝倒。
然而,在一份美国证券文件中,Avadel 表示,FDA 通知它与 FT21...查看全文
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001193805-17-000185 Size: 338 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0000812295-17-000043 Size: 7 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K - Current report Filed: 2017-02-06 AccNo: 0001012477-17-000007 Size: 40 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ EFFECT - Notice of Effectiveness Filed: 2017-01-18 AccNo: 9999999995-17-000132 Size: 1 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-01-10 AccNo: 0001144204-17-001612 Size: 132 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-01-10 AccNo: 0001144204-17-001611 Size: 130 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-01-10 AccNo: 0001144204-17-001609 Size: 131 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K - Current report Filed: 2017-01-11 AccNo: 0001012477-17-000004 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ POS AM - Post-Effective amendments for registration statement Filed: 2017-01-06 AccNo: 0001144204-17-001055 Size: 774 KB 网页链接
$Avadel Pharmaceuticals plc American Depositary Shares(AVDL)$ 8-K12B/A [Amend] - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 1 Filed: 2017-01-06 AccNo: 0001144204-17-000976 Size: 367 KBItem 1.01: Entry into a Mate...